Literature DB >> 7114226

A mechanism for reduced myocardial carnitine levels in diabetic animals.

T C Vary, J R Neely.   

Abstract

The effects of substrates, fasting, and diabetes on carnitine transport into the myocardial cells were characterized in perfused adult rat hearts. Increasing the level of acetyl carnitine and decreasing the level of free carnitine by perfusion with various substrates did not alter the rate of carnitine transport. Carnitine transport was enhanced by the perfusion with palmitate. At low work, addition of 1.2 mM palmitate increased carnitine transport by 33%, whereas high work + 1.2 mM palmitate stimulated transport 60% over that of glucose-perfused hearts. The enhancement of carnitine transport correlated with a rise in tissue levels of long-chain acyl carnitine. When the level of long-chain acyl carnitine was increased prior to measurement of carnitine transport, the enhancement of uptake seen with palmitate as substrate was not observed. Carnitine transport in hearts from 48-h-fasted or diabetic animals was not different from transport in hearts of fed animals. Diabetes resulted in decreased tissue levels of carnitine. The decrease was observed after 48 h of severe diabetes and after several weeks of mild diabetes. In each case, low tissue levels of carnitine were associated with reduced serum carnitine. Serum carnitine decreased to a value near the Km for carnitine transport in diabetic animals. It is concluded that a decreased rate of transport due to lower serum carnitine may be responsible for reduced levels of carnitine seen in diabetic hearts.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114226     DOI: 10.1152/ajpheart.1982.243.2.H154

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Acetyl-L-carnitine increases mitochondrial protein acetylation in the aged rat heart.

Authors:  Janos Kerner; Elizabeth Yohannes; Kwangwon Lee; Ashraf Virmani; Aleardo Koverech; Claudio Cavazza; Mark R Chance; Charles Hoppel
Journal:  Mech Ageing Dev       Date:  2015-02-07       Impact factor: 5.432

Review 2.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

3.  The metabolic effect of carbon monoxide on the heart.

Authors:  H Hattori; N Sugawara; K Nakamura; J Furuno
Journal:  Mol Cell Biochem       Date:  1990-06-25       Impact factor: 3.396

4.  [Decreased plasma carnitine in Type I diabetes mellitus].

Authors:  P Pregant; G Schernthaner; E Legenstein; L Lienhart; S Bruck; C Schnack; E Kaiser
Journal:  Klin Wochenschr       Date:  1991-08-16

5.  No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients.

Authors:  P Pregant; E Kaiser; G Schernthaner
Journal:  Clin Investig       Date:  1993-08

6.  L-carnitine transport in kidney of normotensive, Wistar-Kyoto rats: effect of chronic L-carnitine administration.

Authors:  Lucía Gómez-Amores; Alfonso Mate; Carmen M Vázquez
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

7.  Protection of the ischemic diabetic heart by L-propionylcarnitine therapy.

Authors:  D J Paulson; A L Shug; J Zhao
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

Review 8.  Paradoxical role of lipid metabolism in heart function and dysfunction.

Authors:  N S Dhalla; V Elimban; H Rupp
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

9.  L-carnitine alleviates sciatic nerve crush injury in rats: functional and electron microscopy assessments.

Authors:  Ummü Zeynep Avsar; Umit Avsar; Ali Aydin; Muhammed Yayla; Berna Ozturkkaragoz; Harun Un; Murat Saritemur; Tolga Mercantepe
Journal:  Neural Regen Res       Date:  2014-05-15       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.